CClinicalTrials.gg
Status unknownNCT04328454Updated Mar 31, 2020

Clinical Characteristics and Prognostic Factors of Patients With COVID-19

An observational study in Coronavirus, sponsored by Shanghai 10th People's Hospital. Status unknown at 1 site in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-03-31.

Sponsored by Shanghai 10th People's Hospital · Observational

The sponsor has not verified this record recently (last verified Mar 2020), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
120
Ages
18 Years and older
Sex
All
01

Study summary

As of February 17th, 2020, China has 70635 confirmed cases of coronavirus disease 2019 (COVID-19), including 1772 deaths. Human-to-human spread of virus via respiratory droplets is currently considered to be the main route of transmission. The number of patients increased rapidly but the impact factors of clinical outcomes among hospitalized patients are still unclear.

Read the detailed description

As of February 17th, 2020, China has 70635 confirmed cases of coronavirus disease 2019 (COVID-19), including 1772 deaths. Human-to-human spread of virus via respiratory droplets is currently considered to be the main route of transmission. The number of patients increased rapidly but the impact factors of clinical outcomes among hospitalized patients are still unclear.

02

Conditions studied

  • Coronavirus
03

In context

Coronavirus Infections

929 studies on the registry are indexed under Coronavirus Infections; 50 are open to participants now.

This study's planned enrollment of 120 is below the median of 300 across 334 observational studies indexed under Coronavirus Infections.

Browse Coronavirus Infections studies →

Lead sponsor

Shanghai 10th People's Hospital is the lead sponsor of 167 studies on the registry; 45 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients with COVID-19

Inclusion criteria

  • Adult aged >=18years old; Diagnosed with CONVID19. Diagnostic criteria including: Laboratory (RT-PCR) confirmed SARS-Cov-2 infection; CT of the lung conformed to the manifestation of viral pneumonia.

Exclusion criteria

Exclusion Criteria:

  • Near-death state (expected survival time less than 24 hours); Malignant tumor; Pregnancy or puerperium women; Patients who refused to participant.
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
120 participants (estimated)
Patient registry
No

Groups and cohorts

  • COVID-19 patients

    Hospitalized patients with COVID-19

    Other: retrospective analysis

Interventions

  • Otherretrospective analysis

    The investigators retrospectively analyzed the hospitalized patients with COVID-19

06

What researchers measure

Primary outcomes

  1. Time to negative conversion of severe acute respiratory syndrome coronavirus 2

    The primary outcome is the time to negative conversion of coronavirus

    Time frame: 1 month

Secondary outcomes

  1. Length of stay in hospital

    The time of hospitalization

    Time frame: 1 month

  2. Survival

    The rate of survival within hospitalization of these patients will be tracked. The rate of survival within hospitalization of these patients will be tracked. The rate of survival within hospitalization of these patients will be tracked. The rate of survival within hospitalization of these patients will be tracked.

    Time frame: 1 month

  3. Intubation

    The rate of intubation within hospitalization of these patients will be tracked

    Time frame: 1 month

07

Study locations

1 of 1 sites recruiting
  • Shanghai 10th People's Hospital
    Shanghai, Shanghai +86200072, China
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 31, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04328454
Lead sponsor
Shanghai 10th People's Hospital
Collaborators
Chibi People's Hospital, Hubei Province
Responsible party
Ming Li (Shanghai 10th People's Hospital, Shanghai 10th People's Hospital) — Principal investigator
First posted
Mar 31, 2020
Start date
Jan 30, 2020
Primary completion
Apr 2, 2020 (estimated)
Completion
Apr 15, 2020 (estimated)
Last update
Mar 31, 2020

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion